Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”회신: "리툭시맙을 투여받는 IMID 환자의 코로나19 예방접종: 개인화 요법이 공식화되어야 합니다" Published on 2022-07-012022-09-12 Journal: Journal of the American Academy of Dermatology [키워드] Patient receiving regimen Reply vaccination [저자] Vartan Pahalyants, William S Murphy, Nikolai Klebanov, Chen Lu, Nicholas Theodosakis, Monina R Klevens, Hossein Estiri, Evelyn Lilly, Maryam Asgari, Yevgeniy R Semenov [Category] MERS, 진단, PMC URL [DOI] 10.1016/j.jaad.2022.03.042 [Article Type] Comment [Source] PMC All Keywords 【제목키워드】 vaccination, Patient, regimen, receiving, Reply,